%0 Journal Article %T 星点设计–效应面法优化眼局部应用雷公藤红素纳米结构脂质载体处方
Preparation and Formulation Optimization of Loaded Celastrol Nanostructure Lipid Carriers for Topical Ocular Application %A 郭莹 %A 梁珍 %A 张振 %A 王敬博 %A 张俊杰 %J Hans Journal of Ophthalmology %P 160-168 %@ 2167-6550 %D 2019 %I Hans Publishing %R 10.12677/HJO.2019.84025 %X
目的:采用星点设计–效应面法(CCD-RSM)优化应用于眼局部应用雷公藤红素纳米结构脂质载体(CEL-NLC)处方。方法: 通过测定雷公藤红素在各种脂质的溶解度,筛选出溶解度较好的脂质,采用微乳法制备CEL-NLC,分别以药物/脂质用量比(X1)、表面活性剂/助表面活性剂用量比(X2)为考察对象,以粒径(Y1)、包封率(Y2)和载药量(Y3)为考察指标,经效应面法预测最佳处方,并验证最佳处方。结果:根据CCD-RSM优化得出最佳处方为雷公藤红素40 mg,棕榈酸0.09 g,油酸0.18 g,吐温-80 4.34 g,甘油2.16 g。按最优处方制备的CEL-NLC包封率为(75.28 ± 3.44)%,载药量为(0.45 ± 0.02)%;粒径为(18.66 ± 2.63) nm,多分散指数(PDI)为0.39 ± 0.03。实际值与预测值偏差均小于5%。结论:采用CCD-RSM优化的CEL-NLC处方,包封率高,粒径小,稳定性好,方法可靠,可进一步用于眼局部应用雷公藤红素的后续研究。
Objective: The central composite design-response surface methodology (CCD-RSM) was used to optimize the application of tricorne nanostructured lipid carrier (CEL-NLC) in the local application of eyes. Methods: The lipid with the best solubility was screened out by determining the solubility of celastrol in different lipids. CEL-NLC was prepared by microemulsion technique. Quality of solid lipid (X1), quality of liquid lipid (X2), surfactant/cosurfactant (X3) as objects of investigation, while particle size (Y1), encapsulation efficiency (Y2) and drug loadings rate (Y3) as dependent variables, the optimal prescription was obtained by CCD-RSM and verified subsequently. Results: The best prescription of CEL-NLC was Celastrol 0.04 g, palmitic acid 0.09 g, oleic acid 0.18g, tween-80 4.34 g and Glycerine 2.16 g. The encapsulation efficiency was (75.28 ± 3.44)%; the drug loading rate was (0.45 ± 0.02)%; the particle size was (18.66 ± 2.63) nm. The PDI was 0.39 ± 0.03. The deviation between the measured and predicted values was less than 5%. Conclusion: The optimized CEL-NLC obtained by CCD-RSM has high encapsulation efficiency, small particle size and good stability, which can be further used in the follow-up study of local application of Celastrol in eyes.
%K 雷公藤红素,纳米结构脂质载体,星点设计-效应面法,粒径,包封率,载药量,微乳法
Celastrol %K Nano-Structure Lipid Carrier %K Central Composite Design-Response Surface Methodology %K Encapsulation Rate %K Drug Loading Rate %U http://www.hanspub.org/journal/PaperInformation.aspx?PaperID=33408